• 724 Citations
  • 14 h-Index
20042019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where J. Dobos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
Cell Line Medicine & Life Sciences
SCID Mice Medicine & Life Sciences
zoledronic acid Chemical Compounds
Erythropoietin Medicine & Life Sciences
Microvessels Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 724 Citations
  • 14 h-Index
  • 28 Article

Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases

Baska, F., Sipos, A., Őrfi, Z., Nemes, Z., Dobos, J., Szántai-Kis, C., Szabó, E., Szénási, G., Dézsi, L., Hamar, P., Cserepes, M. T., Tóvári, J., Garamvölgyi, R., Krekó, M. & Őrfi, L., dec. 15 2019, In : European Journal of Medicinal Chemistry. 184, 111710.

Research output: Article

Receptor Protein-Tyrosine Kinases
Phosphotransferases
Acute Myeloid Leukemia
Quinazolines
Aptitude

Targeted drug combination therapy design based on driver genes

Zsákai, L., Sipos, A., Dobos, J., Eros, D., Szántai-Kis, C., Bánhegyi, P., Pató, J., Őrfi, L., Matula, Z., Mikala, G., Kéri, G., Peták, I. & Vályi-Nagy, I., jan. 1 2019, In : Oncotarget. 10, 51, p. 5255-5266 12 p.

Research output: Article

Combination Drug Therapy
Genes
Drug Combinations
Neoplasms
Pharmaceutical Preparations
2 Citations (Scopus)
Epidermal Growth Factor Receptor
Melanoma
Protein-Tyrosine Kinases
Cell Line
PLX4032